Kevin S. Boyle Sr. - 15 Mar 2023 Form 4 Insider Report for Alaunos Therapeutics, Inc. (TCRT)

Role
Chief Executive Officer, Director
Signature
/s/ Melinda Lackey, Attorney-in-Fact
Issuer symbol
TCRT
Transactions as of
15 Mar 2023
Net transactions value
$0
Form type
4
Filing time
17 Mar 2023, 20:30:15 UTC
Previous filing
01 Sep 2022
Next filing
05 Sep 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCRT Employee Stock Option (right to buy) Award $0 +1,800,000 $0.000000 1,800,000 15 Mar 2023 Common Stock 1,800,000 $0.5000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-sixteenth of the shares underlying the option vest in equal quarterly installments measured from January 1, 2023, with the first vesting occuring on April 1, 2023, subject to the Reporting Person's continued service through each such date.